When:
Wednesday, October 1, 2014
12:00 PM - 1:00 PM CT
Where: Robert H Lurie Medical Research Center, Searle Conference Room, 303 E. Superior, Chicago, IL 60611 map it
Audience: Faculty/Staff - Student - Post Docs/Docs
Contact:
Lurie Cancer Center
(312) 695-1304
Group: Robert H Lurie Comprehensive Cancer Center of Northwestern University
Category: Lectures & Meetings
1. NU11ho1: A Phase II Trial of Sequential SGN-35 Therapy with Adriamycin, Vinblastine and Dacarbazine (S-AVD) for Older Patients with Untreated Hodgkin-Lymphoma
Elizabeth Cull, MD
Fellow, Division of Hematology/Oncology
Northwestern University, Feinberg School of Medicine (Chicago, IL)
2. A Phase I Study of BYL719 and Transtuzumab-MCC-DM1-HER2-Positive Metastatic Breast Cancer
Lauren Nye, MD
Fellow, Division of Hematology/Oncology
Northwestern University, Feinberg School of Medicine (Chicago, IL)